Dr. Kami Parsa Launches Mendora and The Skin Repair Formula: A Physician‑Grade Inside‑Out Approach to Post‑Procedure Skin Recovery

Key Highlights
Introduction
Why inside‑out skincare matters for aesthetic outcomes
Ingredient breakdown: what’s inside The Skin Repair Formula and why it matters
The clinical rationale: nutrients, wound healing phases and timing
Manufacturing, testing and clean‑label positioning: what the certifications mean
How clinics and medspas can integrate physician‑grade supplements into protocols
Mendora’s positioning within an expanding nutraceutical market
Evidence summary: what clinical studies say about key ingredients
Safety, interactions and regulatory considerations
Practical guidance for patients: when to start, how long to continue, and what to expect
Dr. Kami Parsa: clinical perspective and why he developed Mendora
Comparative perspectives: how Mendora differs from other skin supplements
Limitations of supplements and where further research is needed
Economic and practice implications for medspas and clinics
Real‑world case scenarios: how supplementation changes the patient journey
How clinicians can evaluate product claims and choose supplements responsibly
Consumer perspective: what patients should ask before starting a clinical‑grade supplement
Outlook: where physician‑formulated nutraceuticals are headed
FAQ

Key Highlights

Mendora, founded by oculoplastic surgeon Dr. Kami Parsa, debuts The Skin Repair Formula: a daily powdered supplement blending pasture‑raised collagen peptides with hyaluronic acid, ceramides, vitamin C, biotin, zinc and astaxanthin to support skin repair and long‑term results after aesthetic procedures.
The product targets a clinical gap—nutritional support before and after laser, microneedling, radiofrequency and surgical procedures—while meeting third‑party testing, cGMP manufacturing and clean‑label standards for medspa and direct‑to‑consumer use.

Introduction

Patients and clinicians increasingly recognize that topical creams and in‑office procedures address visible layers of skin, but structural repair and durable outcomes require nutritional building blocks delivered from within. Mendora, a new skincare ecosystem created by Beverly Hills oculoplastic surgeon Dr. Kami Parsa, aims to bridge that gap. Its flagship product, The Skin Repair Formula, is a powdered, daily supplement engineered to support wound healing, hydration, collagen synthesis and protection against oxidative stress—factors that determine how quickly and how well skin recovers after aesthetic interventions.

The launch follows more than two decades of periocular reconstructive work and thousands of facial procedures by Dr. Parsa. It positions a clinician‑led nutraceutical at the intersection of aesthetic medicine and evidence‑based supplementation, and invites a closer look at what ingredients matter, why timing and formulation affect outcomes, and how medspas and aesthetic clinics can integrate clinical‑grade supplements into patient care pathways.

Why inside‑out skincare matters for aesthetic outcomes

Procedures that remodel skin—ablative lasers, fractional resurfacing, microneedling, radiofrequency and surgical lifts—create controlled injury. The visible benefits of those procedures depend on organized repair: new collagen deposition, restoration of the extracellular matrix, rehydration and re‑establishment of barrier lipids. When the body lacks the raw materials or metabolic cofactors to rebuild tissue efficiently, repair slows and complications—prolonged erythema, poor scar formation, inconsistent texture improvement—become more likely.

Clinicians have long used topical agents to modulate healing and reduce infection risk. Supplements aim to complement those interventions. Nutrients such as specific collagen peptides, vitamin C and zinc are involved directly in collagen synthesis and crosslinking. Lipid components like ceramides support barrier restoration. Hydration molecules such as hyaluronic acid help maintain turgor and reduce mechanical stress on migrating keratinocytes. Antioxidants like astaxanthin reduce oxidative damage that can otherwise degrade nascent matrix proteins and impede cellular signaling.

Anecdotal reports from aesthetic clinics suggest that patients who adopt pre‑ and post‑procedure nutritional regimens often experience shorter recovery windows and more consistent outcomes. Randomized trials and mechanistic studies offer additional support for targeted supplementation as an adjunct to procedural care, though the quality of evidence varies by ingredient. The approach promoted by Mendora aligns the supplement’s composition with recognized biological processes in wound healing and tissue remodeling.

Ingredient breakdown: what’s inside The Skin Repair Formula and why it matters

Mendora’s formula combines multiple active ingredients that aim to act synergistically. Understanding each component clarifies how a combined product may support the phases of repair.

Collagen peptides (pasture‑raised, grass‑fed): Oral collagen peptides are hydrolyzed fragments that are absorbed as di‑ and tri‑peptides and amino acids. Clinical trials indicate that regular intake can increase skin elasticity, improve hydration and reduce fine lines over several weeks to months. Peptides provide substrates for fibroblasts and may stimulate endogenous collagen synthesis through signaling pathways. The choice of pasture‑raised, grass‑fed sourcing appeals to consumers concerned about farm practices and perceived product purity, though functional outcomes depend on peptide composition and dose.
Hyaluronic acid (oral): HA is a glycosaminoglycan critical for tissue hydration. Oral low‑molecular‑weight HA supplements have been associated with increased skin moisture and improvement in wrinkle parameters in placebo‑controlled studies. HA supports the extracellular matrix and facilitates cell migration during re‑epithelialization.
Ceramides: Ceramides are essential lipids in the stratum corneum that regulate barrier function and transepidermal water loss. Oral preparations—often derived from wheat or rice and marketed as phytoceramides—have been shown to improve skin hydration and barrier integrity, which can reduce irritation and accelerate the return to normal function after barrier‑disrupting treatments.
Vitamin C: A cofactor for prolyl and lysyl hydroxylases, vitamin C is indispensable for proper collagen crosslinking and stabilization. It also has antioxidant properties and supports immune function in the skin. Sufficient vitamin C status is required for optimal collagen deposition during healing.
Biotin (vitamin B7): Biotin supports keratin infrastructure. While benefits for hair growth and nail strength are most evident in deficiency states, many people report improved nail brittleness with supplementation. For patients undergoing procedures that stress appendages—such as periocular microneedling or full‑face resurfacing—supporting keratin health can be a practical adjunct.
Zinc: Integral to DNA synthesis, cell proliferation and immune regulation, zinc accelerates wound healing and reduces inflammation and infection risk when levels are adequate. Zinc deficiency impairs re‑epithelialization and collagen deposition.
Astaxanthin: A carotenoid with potent antioxidant activity, astaxanthin helps neutralize reactive oxygen species generated during inflammation and UV exposure. Antioxidants protect forming collagen and cellular proteins from oxidative damage during the early, vulnerable phases of repair.

Combined in a single daily powder, these components target structural substrates (collagen), hydration (HA, ceramides), enzymatic cofactors (vitamin C, zinc), structural vitamins (biotin) and oxidative protection (astaxanthin). The powdered format can facilitate absorption and is often preferable for patients who struggle with large pills.

The clinical rationale: nutrients, wound healing phases and timing

Wound healing unfolds in overlapping stages: hemostasis, inflammation, proliferation (granulation, angiogenesis, fibroplasia) and remodeling. Each stage has distinct nutrient demands.

Early inflammation requires immune competence. Zinc and antioxidants modulate inflammatory responses and control oxidative stress. Excessive or prolonged inflammation degrades matrix proteins and delays progression to the proliferative phase.
Proliferation demands amino acids for collagen and matrix proteins, and cofactors for enzymatic hydroxylation. Collagen peptides and vitamin C are centrally involved. Collagen peptides supply the substrate; vitamin C enables proper crosslinking.
Remodeling reshapes and strengthens the new matrix over weeks to months. Continued availability of substrates and cofactors supports tensile strength development and long‑term outcomes.

Timing also affects efficacy. Starting supplementation prior to a procedure builds systemic reserves and places cells in a reparative metabolic milieu at the moment of controlled injury. Post‑procedure continuation sustains the supply of building blocks during the crucial proliferative and remodeling windows. Clinics that standardize pre‑ and post‑procedural nutrition protocols—often starting 1–2 weeks before invasive resurfacing procedures and continuing for 6–12 weeks afterwards—report fewer complications and faster epithelial healing in observational practice, though randomized controlled trials on formal protocols are limited.

Integrating supplements into perioperative care also requires attention to interactions with other medications and comorbidities. For example, vitamin C increases iron absorption, which can affect patients with hemochromatosis; zinc can interfere with copper absorption when used long term. Clinicians should assess nutritional baselines and adapt recommendations.

Manufacturing, testing and clean‑label positioning: what the certifications mean

Mendora emphasizes third‑party testing and cGMP‑certified manufacturing. Those markers matter for clinicians and consumers who demand consistency, transparency and safety.

cGMP (current Good Manufacturing Practice): These are FDA‑aligned regulations that dictate manufacturing controls—cleanliness, record keeping, batch testing and consistent production. cGMP certification does not equate to FDA approval of products, but it does reduce the risk of contamination and label‑claim variance.
Third‑party testing: Independent assays validate identity, potency and purity. They can screen for heavy metals, microbial contaminants and verify ingredient concentrations. Reputable third‑party testing provides a certificate of analysis (COA) that medspas and clinicians can request to confirm claims.
Clean‑label attributes (dairy‑free, gluten‑free, soy‑free, non‑GMO, no artificial preservatives/flavors/sweeteners): These designations meet consumer demand for fewer allergens and perceived purity. They also simplify integration into patient regimens for those with dietary restrictions or sensitivities.

Together, these standards reduce variability between batches and help clinicians adopt supplements with greater confidence. For product developers, aligning sourcing (e.g., pasture‑raised, grass‑fed collagen) with manufacturing transparency addresses both safety and marketing considerations.

How clinics and medspas can integrate physician‑grade supplements into protocols

Clinics that incorporate inside‑out strategies formalize protocols to optimize patient outcomes and create clear communication channels. Practical steps include:

Pre‑procedure screening: Assess dietary habits, supplement use, medication interactions and baseline micronutrient status—particularly if a patient has signs of malnutrition, restrictive diets or chronic illnesses that impair absorption.
Patient education: Explain how supplementation complements, but does not replace, procedural care and topical post‑procedure regimens. Set realistic expectations about timing—nutritional regimens enhance repair over weeks to months; they do not offer immediate procedural effects.
Timing protocols: Many clinicians recommend starting a collagen‑containing regimen 1–2 weeks before resurfacing or surgical procedures and continuing for at least 6–12 weeks post‑procedure. For less invasive treatments, shorter preconditioning windows may still offer benefit.
Standardized kits: Bundling supplements with post‑procedure kits—cleanser, topical agents, sun protection and written care instructions—streamlines adherence. Offering the supplement through the practice reinforces continuity of care and allows clinicians to monitor outcomes.
Monitoring and documentation: Track healing timelines, complication rates and patient‑reported outcomes. Even simple before‑and‑after photography and standardized questionnaires help practices assess whether integrating supplementation affects recovery metrics.

Real‑world example: A midsize medspa introduced a pre‑procedure nutrition protocol centered on a collagen–vitamin C powder for patients scheduled for CO2 fractional resurfacing. Over six months, clinicians noted earlier re‑epithelialization and reduced reports of severe post‑procedure discomfort. While not a controlled trial, the practice used those observations to refine patient counseling and to encourage adherence by including the supplement in the procedure fee. This approach demonstrates how clinician‑led adoption can create practice‑specific evidence and improve patient satisfaction.

Mendora’s positioning within an expanding nutraceutical market

The aesthetic industry has seen an influx of physician‑formulated nutraceuticals over the last decade. Drivers include patient desire for non‑invasive augmentations to topical and in‑office treatments, increasing evidence for oral interventions, and the credibility conferred by clinician founders.

Mendora differentiates itself along several axes:

Clinical provenance: A founder with surgical and academic credentials in oculoplastics brings procedural insight into the formulation, particularly given the delicate anatomy and healing needs of the periocular region.
Focus on recovery: While many beauty supplements emphasize long‑term cosmetic benefits, Mendora highlights peri‑procedural healing and maintaining clinician‑delivered results.
Wholesale for medspas and clinics: By offering a partner program, the brand seeks institutional adoption rather than only direct consumer sales. This aligns product distribution with clinical workflows and clinician recommendations.

The nutraceutical landscape remains competitive. Other brands offer collagen powders, ceramide supplements, or antioxidant complexes with varying evidence bases and transparency. Buyers increasingly evaluate not just ingredient lists but sourcing, testing, and clinician endorsement. Practices that curate a concise, evidence‑aligned supplement offering reduce patient confusion and strengthen the perceived value of in‑office interventions.

Evidence summary: what clinical studies say about key ingredients

Research quality and volume vary by ingredient. Summarizing established findings clarifies reasonable expectations.

Oral collagen peptides: Multiple randomized, placebo‑controlled trials report improvements in skin elasticity, hydration and reduced wrinkle depth after 8–12 weeks of daily supplementation with hydrolyzed collagen at doses commonly between 2.5–10 g/day. Mechanistic studies show collagen peptides circulate and may increase dermal fibroblast activity.
Hyaluronic acid: Controlled trials have found oral HA supplements can increase skin moisture and elasticity. Molecular weight and dosing influence outcomes, with low‑molecular‑weight preparations typically used for oral formulations.
Ceramides: Clinical data on phytoceramides indicate improvements in skin hydration and barrier function within weeks. The effect size depends on dose and baseline skin condition.
Vitamin C: Strong mechanistic evidence supports its role in collagen formation. Clinical studies on oral vitamin C alone for cosmetic outcomes are mixed, but deficiency clearly impairs healing and collagen synthesis.
Zinc: Robust clinical and experimental data link zinc to wound healing. Deficiency causes delayed wound closure; supplementation corrects deficits and improves healing in deficient populations.
Biotin: Benefits for brittle nails and hair are most pronounced in deficiency states. Placebo‑controlled trials outside of confirmed deficiency provide mixed results.
Astaxanthin: Clinical trials indicate antioxidant and photoprotective benefits, with some evidence of improved skin elasticity and reduced wrinkle formation after daily supplementation.

Taken together, the ingredients in Mendora reflect mechanisms that are relevant to repair and recovery. However, the cumulative clinical benefit of combined formulations versus isolated ingredients is less explored in large randomized trials, making real‑world evidence from clinics and post‑marketing surveillance valuable.

Safety, interactions and regulatory considerations

Dietary supplements occupy a distinct regulatory niche. They are not subject to pre‑market approval by the FDA in the way drugs are. Manufacturers are responsible for ensuring safety and accurate labeling, and claims must avoid implying disease treatment or prevention.

Safety and interaction considerations:

Allergens and sources: Mendora’s claims of dairy‑free, gluten‑free and soy‑free reduce allergen risk for many users. The use of pasture‑raised, grass‑fed collagen may be important for patients with concerns about bovine sourcing; however, individuals with specific allergies should review ingredient origins carefully.
Drug interactions: High doses of vitamin C can affect certain medications and increase iron absorption. Zinc supplements can interfere with the absorption of certain antibiotics and copper. Patients on anticoagulants, immunosuppressants or with chronic medical conditions should consult their physician before starting any new supplement.
Pregnancy and breastfeeding: Many supplements lack robust safety data in pregnancy. Pregnant or breastfeeding patients should seek medical advice before initiating supplementation.
Contaminant screening: Third‑party testing reduces the risk of heavy-metal contamination and undeclared compounds. Practices can request COAs to confirm testing results.
Label claims: Brands must avoid making therapeutic claims that would classify a product as a drug. Positioning as an adjunct to promote skin health and support recovery—without promising cure or prevention of disease—aligns with regulatory norms.

Clinicians recommending supplements should document informed consent, discuss potential interactions, and where appropriate, consider baseline nutrient testing for at‑risk populations.

Practical guidance for patients: when to start, how long to continue, and what to expect

General practice patterns emerging in aesthetic clinics provide a framework, though individualized care remains paramount.

Start window: For invasive resurfacing or surgical lifts, beginning supplementation 1–2 weeks pre‑procedure builds substrate availability and supports immune competence. For less invasive procedures, a shorter preconditioning phase may suffice.
Duration: Continue daily supplementation for at least 6–12 weeks post‑procedure to support the proliferative and early remodeling phases. For maintenance beyond procedural recovery, ongoing daily use is common among cosmetically motivated patients.
Expected timeline: Improvements in skin hydration and patient‑reported texture may be noticeable within 4–8 weeks. Structural changes such as increased elasticity and collagen remodeling typically manifest over months.
Adherence strategies: Powdered formulations mixed into beverages or smoothies are easier for many patients to take consistently than multiple pills. Clinicians can bundle supplements with post‑procedure kits and provide written instructions to improve adherence.
Monitoring: Track healing milestones—time to re‑epithelialization, patient pain scores, infection incidence, and photographic documentation. Use these metrics to refine practice protocols and patient education materials.

Encourage patients to report adverse effects promptly and to coordinate supplement use with other vitamins or over‑the‑counter products to avoid excessive cumulative doses (e.g., combined vitamin C from multivitamins and supplements).

Dr. Kami Parsa: clinical perspective and why he developed Mendora

Dr. Parsa brings a clinician’s eye to a gap he observed after performing thousands of facial procedures over two decades. Oculoplastic and reconstructive surgery demands meticulous attention to healing dynamics in a region where tissue laxity, thin skin and vascular supply influence outcomes. From his experience, available topical regimens and isolated supplements often fell short in providing the combined nutritional support necessary for optimal repair.

His statement—highlighting that proper nutritional support dramatically improves patient outcomes—reflects a broader movement among proceduralists to view outcomes through a holistic lens. As a clinical professor and peer‑reviewed author, Dr. Parsa translated procedural observations into a formulation that mirrors the biological demands of repair: structural peptides, hydration molecules, barrier components, enzymatic cofactors and antioxidants.

That Mendora offers wholesale partnerships with medspas and aesthetic clinics suggests an intent to integrate supplementation within a clinical pathway rather than solely competing in the crowded consumer beauty market. This positioning strengthens the link between procedural care and follow‑through at home.

Comparative perspectives: how Mendora differs from other skin supplements

The market contains numerous collagen powders, biotin supplements and antioxidant complexes. Mendora differentiates through:

Combined, targeted formulation for peri‑procedural support: Many products target general beauty benefits rather than repair after controlled injury.
Clinical founding and medspa distribution: Physician backing and wholesale channels enable clinician oversight and patient counseling.
Quality and sourcing claims: cGMP manufacturing, third‑party testing, and specific sourcing (pasture‑raised, grass‑fed collagen) respond to clinician expectations for traceability.
Clean‑label attributes: Allergen‑free and non‑GMO designations broaden patient suitability.

Consumers should evaluate supplements on ingredient composition, evidence for the specific product formulation, manufacturing transparency and whether the product aligns with their clinical needs and practitioner advice.

Limitations of supplements and where further research is needed

Supplements are adjuncts, not replacements, for skilled procedural technique and postoperative care. Gaps in evidence remain:

Combined formulation trials: Large randomized trials testing multicomponent supplements like Mendora’s against placebo in the peri‑procedural setting are limited. Such studies would clarify whether additive or synergistic benefits exceed those of individual components.
Dose‑response relationships: Optimal dosing for long‑term remodeling versus short‑term repair remains to be standardized, particularly for collagen peptides and phytoceramides.
Population heterogeneity: Responses may vary by age, baseline nutritional status, skin type, and comorbidities. Stratified research could inform personalized protocols.
Long‑term safety: Extended use studies can evaluate micronutrient interactions, cumulative nutrient exposure and effects in populations with chronic health conditions.

Clinicians can contribute to the evidence base through structured observational data collection, registry development and collaboration on controlled trials with supplement manufacturers.

Economic and practice implications for medspas and clinics

Offering physician‑grade supplements has business and clinical implications:

Revenue model: Supplements create an ancillary revenue stream that can be packaged with procedures. Wholesale partnerships typically come with practice support materials and patient education resources.
Patient retention and satisfaction: A structured peri‑procedural protocol that includes supplementation can improve perceived value and strengthen the clinician‑patient relationship.
Liability and documentation: Recommending or dispensing supplements requires proper documentation and informed consent. Practices should have protocols for screening contraindications and for documenting counseling.
Inventory and logistics: Powdered supplements require storage, and practices should manage inventory, returns and COA requests. Clear labeling and patient instructions reduce misuse.

From a clinical standpoint, adopting supplementation should align with evidence‑based protocols and with the practice’s standard of care.

Real‑world case scenarios: how supplementation changes the patient journey

Scenario A: Fractional CO2 resurfacing A patient in her early 50s undergoes fractional CO2 resurfacing for photodamaged skin. The practice advises starting a collagen‑vitamin C powder 10 days prior and continuing for 8 weeks. The patient adheres and reports reduced downtime compared with a friend who did not supplement; clinicians note earlier crust shedding and faster restoration of skin texture. While anecdotal, such experiences are common in clinics that emphasize peri‑procedural nutrition and underscore how supplementation can improve patient satisfaction.

Scenario B: Blepharoplasty (eyelid surgery) A patient undergoing upper and lower blepharoplasty is counseled about postoperative swelling and scar maturation. The surgeon recommends a supplement containing collagen peptides, zinc and vitamin C to support collagen formation and re‑epithelialization. Over months, the patient reports smoother scar texture and quicker resolution of edema. Given the periocular skin’s thinness and limited subcutaneous tissue, providing internal support may reduce tension on healing incisions and promote more favorable remodeling.

These scenarios illustrate plausible pathways by which supplements can influence healing dynamics. They do not substitute for controlled evidence but provide context for clinician rationale.

How clinicians can evaluate product claims and choose supplements responsibly

Clinicians should apply the same critical appraisal used for other clinical products:

Request COAs and review independent testing for contaminants and potency.
Evaluate ingredient doses against clinical studies to determine whether the product provides therapeutically relevant amounts.
Consider sourcing and manufacturing controls—traceability, cGMP compliance and supplier audits reduce risk.
Assess the clarity of labeling: complete ingredient lists, potential allergens and recommended dosing.
Prefer brands that offer medical liaisons or clinician education for integration into practice.

Prudent clinicians pilot new supplements with a subset of patients, document outcomes, and adjust protocols based on observed results and evolving evidence.

Consumer perspective: what patients should ask before starting a clinical‑grade supplement

Patients considering The Skin Repair Formula or similar products should ask:

Is this supplement recommended by my treating clinician for my specific procedure and medical history?
Has the product been third‑party tested, and can I see the certificate of analysis?
What are the ingredients and their exact doses per serving?
Are there any potential interactions with my medications or conditions?
When should I start the supplement relative to my procedure, and how long should I continue it?
Are there known side effects or reported adverse events?

These questions help patients make informed choices and encourage collaborative care between patients and clinicians.

Outlook: where physician‑formulated nutraceuticals are headed

Physician‑led brands like Mendora reflect a maturation of the aesthetic supplement market. Expect three converging trends:

Tighter clinical integration: More practices will adopt formal pre‑ and post‑procedure nutrition protocols tied to measurable outcomes.
Greater transparency: Demand for COAs, batch traceability and clear sourcing will drive manufacturers to disclose more information.
Evidence development: Manufacturers with clinician partners are well positioned to support real‑world evidence generation and controlled studies that clarify efficacy and dosing.

As the market evolves, clinicians will play a crucial role in mediating expectations, documenting outcomes and ensuring patient safety.

FAQ

Q: What is Mendora The Skin Repair Formula intended for? A: The Skin Repair Formula is a daily powdered supplement formulated to support skin repair, hydration, collagen synthesis and protection against oxidative stress. It is positioned as an adjunct to cosmetic procedures—such as laser resurfacing, microneedling, radiofrequency treatments and surgical interventions—to help optimize recovery and maintain long‑term results.

Q: Who developed Mendora and why? A: Dr. Kami Parsa, an oculoplastic and reconstructive surgeon with over two decades of facial surgery experience, developed Mendora after observing that many patients lacked adequate nutritional support before and after procedures. The formulation reflects clinical priorities for tissue repair and long‑term skin health based on procedural experience.

Q: What are the key ingredients and how do they work? A: Key ingredients include hydrolyzed collagen peptides, hyaluronic acid, ceramides, vitamin C, biotin, zinc and astaxanthin. Collagen peptides provide substrates and signaling for dermal repair; vitamin C supports enzymatic crosslinking of collagen; HA and ceramides support hydration and barrier function; zinc aids cell proliferation and immune regulation; biotin supports keratin health; astaxanthin offers antioxidant protection.

Q: Is there clinical evidence supporting these ingredients? A: Individual ingredients—such as collagen peptides, HA, ceramides, vitamin C and zinc—have clinical and mechanistic evidence supporting roles in skin hydration, elasticity and wound healing. Combined‑formula randomized trials specifically testing multicomponent products in peri‑procedural settings are less common; observational data from clinical practice provide additional context.

Q: How should patients use the product around procedures? A: Practices commonly recommend starting supplementation 1–2 weeks before invasive procedures and continuing for at least 6–12 weeks afterward to support proliferative and remodeling phases of healing. Specific timing should be individualized and discussed with the treating clinician.

Q: Are there safety concerns or interactions? A: The product is marketed as dairy‑free, gluten‑free, soy‑free, non‑GMO and free of artificial preservatives and sweeteners. Potential interactions exist: for example, zinc can interfere with certain antibiotics and copper absorption; high vitamin C doses affect iron uptake. Patients who are pregnant, breastfeeding, have chronic diseases or take prescription medications should consult their healthcare provider before use.

Q: How does Mendora ensure product quality? A: Mendora states that the product is manufactured in cGMP‑certified facilities and undergoes third‑party testing for purity and potency. Clinicians and patients may request certificates of analysis from the manufacturer to verify batch testing.

Q: Can supplements replace proper procedural technique or topical care? A: No. Supplements are intended to complement procedural excellence and evidence‑based topical post‑procedure care. They provide internal support but do not replace surgical skill, sterile technique or appropriate wound management.

Q: Where can clinicians and patients obtain Mendora? A: The Skin Repair Formula is available direct‑to‑consumer via the company website and through a wholesale partnership program for medspas and clinics nationwide. Clinicians interested in offering the product to patients can contact the manufacturer to learn about partnership options and practice integration.

Q: What future research is needed? A: Large randomized controlled trials testing multicomponent supplements in peri‑procedural settings would clarify the magnitude of benefit, optimal doses, and ideal timing. Long‑term safety studies and stratified research by age, skin type and comorbidity would inform personalized care pathways.

The launch of Mendora and The Skin Repair Formula spotlights a growing recognition within aesthetic medicine: durable procedural outcomes depend as much on the tissue’s capacity to rebuild as on the precision of the intervention. By aligning formulation with the biological stages of repair and emphasizing manufacturing transparency, clinician‑led supplements offer a path for practices to systematize peri‑procedural nutrition and potentially improve recovery trajectories. Clinicians should evaluate product evidence, request independent testing, document outcomes and counsel patients on integration—balancing promise with measured appraisal of the existing evidence.